KCNK5 and inflammatory bowel disease: The lack of selective K2P5.1 blockers may facilitate future research on a novel high-throughput screening system to detect small molecule K2P5.1 modulators and the regulatory mechanisms underlying K2P5.1 transcription, translation, and protein degradation in IBD.